1. Home
  2. CLDX vs NSP Comparison

CLDX vs NSP Comparison

Compare CLDX & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • NSP
  • Stock Information
  • Founded
  • CLDX 1983
  • NSP 1986
  • Country
  • CLDX United States
  • NSP United States
  • Employees
  • CLDX N/A
  • NSP N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • NSP Professional Services
  • Sector
  • CLDX Health Care
  • NSP Consumer Discretionary
  • Exchange
  • CLDX Nasdaq
  • NSP Nasdaq
  • Market Cap
  • CLDX 2.9B
  • NSP 3.2B
  • IPO Year
  • CLDX 2008
  • NSP 1997
  • Fundamental
  • Price
  • CLDX $23.55
  • NSP $73.05
  • Analyst Decision
  • CLDX Buy
  • NSP Hold
  • Analyst Count
  • CLDX 8
  • NSP 4
  • Target Price
  • CLDX $64.83
  • NSP $95.67
  • AVG Volume (30 Days)
  • CLDX 1.1M
  • NSP 462.2K
  • Earning Date
  • CLDX 11-06-2024
  • NSP 10-31-2024
  • Dividend Yield
  • CLDX N/A
  • NSP 3.28%
  • EPS Growth
  • CLDX N/A
  • NSP N/A
  • EPS
  • CLDX N/A
  • NSP 3.16
  • Revenue
  • CLDX $9,976,000.00
  • NSP $6,547,871,000.00
  • Revenue This Year
  • CLDX N/A
  • NSP $2.24
  • Revenue Next Year
  • CLDX N/A
  • NSP $5.31
  • P/E Ratio
  • CLDX N/A
  • NSP $23.16
  • Revenue Growth
  • CLDX 128.55
  • NSP 2.38
  • 52 Week Low
  • CLDX $23.49
  • NSP $72.74
  • 52 Week High
  • CLDX $53.18
  • NSP $119.41
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 29.53
  • NSP 34.66
  • Support Level
  • CLDX $25.56
  • NSP $77.50
  • Resistance Level
  • CLDX $28.15
  • NSP $81.54
  • Average True Range (ATR)
  • CLDX 1.62
  • NSP 3.42
  • MACD
  • CLDX 0.14
  • NSP -0.38
  • Stochastic Oscillator
  • CLDX 1.27
  • NSP 2.35

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

Share on Social Networks: